Work

389 A phase 1, dose-escalation, first-in-human study of ARQ 087, an oral pan-FGFR inhibitor, in adult subjects with advanced solid tumors

Year: 2014

Type: article

Study design: Clinical Trial

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(14)70515-5

Authors: K. Papadopoulos, A. Tolcher, M. Kittaneh, A. Patniak, D. Rasco, G. Chambers, G. Newth, R. Savage, T. Hall, B. Schwartz, J. Kazakin, P. LoRusso

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1998353524

FWCI: 0.243

Cites:

Cited by: 1

Related to: 10